A detailed history of Ubs Group Ag transactions in Uni Qure N.V. stock. As of the latest transaction made, Ubs Group Ag holds 5,075 shares of QURE stock, worth $32,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,075
Previous 26,708 81.0%
Holding current value
$32,581
Previous $138,000 84.06%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.39 - $5.43 $94,968 - $117,467
-21,633 Reduced 81.0%
5,075 $22,000
Q1 2024

May 13, 2024

SELL
$4.82 - $6.93 $681,037 - $979,167
-141,294 Reduced 84.1%
26,708 $138,000
Q4 2023

Feb 09, 2024

BUY
$5.63 - $8.27 $459,030 - $674,277
81,533 Added 94.29%
168,002 $1.14 Million
Q3 2023

Nov 09, 2023

BUY
$6.71 - $11.83 $466,566 - $822,575
69,533 Added 410.56%
86,469 $580,000
Q2 2023

Aug 11, 2023

SELL
$11.12 - $22.2 $751,889 - $1.5 Million
-67,616 Reduced 79.97%
16,936 $194,000
Q1 2023

May 12, 2023

SELL
$18.7 - $23.07 $744,933 - $919,016
-39,836 Reduced 32.03%
84,552 $1.7 Million
Q4 2022

Feb 08, 2023

BUY
$18.12 - $27.32 $1.37 Million - $2.07 Million
75,730 Added 155.64%
124,388 $2.82 Million
Q3 2022

Nov 10, 2022

SELL
$16.98 - $25.54 $385,921 - $580,473
-22,728 Reduced 31.84%
48,658 $912,000
Q2 2022

Aug 10, 2022

SELL
$13.15 - $20.45 $1.83 Million - $2.84 Million
-138,794 Reduced 66.04%
71,386 $1.33 Million
Q1 2022

May 16, 2022

BUY
$14.54 - $21.5 $909,491 - $1.34 Million
62,551 Added 42.37%
210,180 $3.8 Million
Q4 2021

Feb 14, 2022

BUY
$20.24 - $36.01 $2.04 Million - $3.63 Million
100,777 Added 215.1%
147,629 $3.06 Million
Q3 2021

Nov 15, 2021

BUY
$26.01 - $38.22 $322,315 - $473,622
12,392 Added 35.96%
46,852 $1.5 Million
Q2 2021

Aug 13, 2021

SELL
$29.97 - $37.17 $1.18 Million - $1.46 Million
-39,310 Reduced 53.29%
34,460 $1.06 Million
Q1 2021

May 12, 2021

BUY
$29.24 - $42.03 $1.79 Million - $2.58 Million
61,305 Added 491.82%
73,770 $2.49 Million
Q4 2020

Feb 11, 2021

SELL
$35.35 - $50.67 $897,501 - $1.29 Million
-25,389 Reduced 67.07%
12,465 $450,000
Q3 2020

Nov 12, 2020

BUY
$35.98 - $47.66 $476,806 - $631,590
13,252 Added 53.87%
37,854 $1.39 Million
Q2 2020

Jul 31, 2020

SELL
$45.06 - $67.74 $436,406 - $656,061
-9,685 Reduced 28.25%
24,602 $1.11 Million
Q1 2020

May 01, 2020

BUY
$40.01 - $73.97 $389,737 - $720,541
9,741 Added 39.68%
34,287 $1.63 Million
Q4 2019

Feb 14, 2020

BUY
$37.13 - $74.62 $47,266 - $94,991
1,273 Added 5.47%
24,546 $1.76 Million
Q3 2019

Nov 14, 2019

BUY
$39.36 - $76.8 $63,290 - $123,494
1,608 Added 7.42%
23,273 $917,000
Q2 2019

Aug 14, 2019

BUY
$52.76 - $82.19 $1.04 Million - $1.63 Million
19,799 Added 1061.04%
21,665 $1.69 Million
Q1 2019

May 14, 2019

SELL
$27.39 - $68.41 $17,255 - $43,098
-630 Reduced 25.24%
1,866 $112,000
Q4 2018

Feb 14, 2019

SELL
$22.8 - $33.93 $186,960 - $278,226
-8,200 Reduced 76.66%
2,496 $72,000
Q3 2018

Nov 14, 2018

SELL
$29.75 - $43.08 $233,091 - $337,531
-7,835 Reduced 42.28%
10,696 $389,000
Q2 2018

Aug 14, 2018

BUY
$21.96 - $39.94 $396,334 - $720,837
18,048 Added 3736.65%
18,531 $700,000
Q1 2018

May 15, 2018

SELL
$17.1 - $26.61 $29,360 - $45,689
-1,717 Reduced 78.05%
483 $11,000
Q4 2017

Feb 14, 2018

SELL
$9.47 - $19.59 $28,694 - $59,357
-3,030 Reduced 57.93%
2,200 $43,000
Q3 2017

Nov 14, 2017

SELL
$7.7 - $9.6 $3,418 - $4,262
-444 Reduced 7.83%
5,230 $50,000
Q2 2017

Aug 14, 2017

BUY
N/A
274 Added 5.07%
5,674 $35,000
Q1 2017

Nov 14, 2017

BUY
N/A
5,400
5,400 $31,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.